Schedule 13G ownership disclosure

Xencor Inc

Common Stock, par value $0.01 per share · CUSIP: 98401F105

Event date: 2025-10-09

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BIOTECHNOLOGY VALUE FUND L P

    Shares: 2,467,127.00 · Class: 3.5%

  • BVF I GP LLC

    Shares: 2,467,127.00 · Class: 3.5%

  • BIOTECHNOLOGY VALUE FUND II LP

    Shares: 1,793,209.00 · Class: 2.5%

  • BVF II GP LLC

    Shares: 1,793,209.00 · Class: 2.5%

  • Biotechnology Value Trading Fund OS LP

    Shares: 286,542.00 · Class: 0.4%

  • BVF Partners OS Ltd.

    Shares: 286,542.00 · Class: 0.4%

  • BVF GP HOLDINGS LLC

    Shares: 4,260,336.00 · Class: 6.0%

  • BVF PARTNERS L P/IL

    Shares: 4,619,341.00 · Class: 6.5%

  • BVF INC/IL

    Shares: 4,619,341.00 · Class: 6.5%

  • LAMPERT MARK N

    Shares: 4,619,341.00 · Class: 6.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-25-002762
Form type
SCHEDULE 13G
Filer
BIOTECHNOLOGY VALUE FUND L P
CIK
CIK 918923
Filed
Oct 17, 2025
Reporting period
Oct 09, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub